Immunic’s (IMUX) Buy Rating Reiterated at B. Riley
B. Riley restated their buy rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a report released on Wednesday,Benzinga reports. The firm currently has a $6.00 target price on the stock. B. Riley also issued estimates for Immunic’s Q1 2025 earnings at ($0.26) EPS, Q2 2025 earnings at ($0.16) EPS, Q3 2025 earnings at […]
B. Riley restated their buy rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a report released on Wednesday,Benzinga reports. The firm currently has a $6.00 target price on the stock. B. Riley also issued estimates for Immunic’s Q1 2025 earnings at ($0.26) EPS, Q2 2025 earnings at ($0.16) EPS, Q3 2025 earnings at […]
